The patent for that vaccine was held jointly by Kenyan and British scientists, who had agreed to use their ownership to help ensure that the vaccine, should it prove effective, would be made available at reasonable prices to Kenya and other developing countries.
La patente de esa vacuna es propiedad conjunta de científicos kenianos y británicos, quienes han convenido en utilizar su propiedad para ayudar a que la vacuna, en caso de resultar eficaz, se distribuya a precios razonables en Kenya y otros países en desarrollo.